Understanding AbbVie Stock Decline: Key Reasons Behind Monday’s Drop
Disappointing news from the laboratory weighed on AbbVie (NYSE: ABBV) stock as the trading week kicked off. The company had high hopes for a schizophrenia drug it was developing; however,…